Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-063024
Filing Date
2023-03-07
Accepted
2023-03-07 16:42:53
Documents
7
Period of Report
2023-04-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d417044ddef14a.htm DEF 14A 676389
2 GRAPHIC g417044dsp1a.jpg GRAPHIC 17858
3 GRAPHIC g417044g0224071627751.jpg GRAPHIC 3731
4 GRAPHIC g417044g0224071628329.jpg GRAPHIC 23121
5 GRAPHIC g417044g0224071628626.jpg GRAPHIC 19017
6 GRAPHIC g417044g27u30.jpg GRAPHIC 152135
7 GRAPHIC g417044g34e99.jpg GRAPHIC 95660
  Complete submission text file 0001193125-23-063024.txt   1100021
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34375 | Film No.: 23713212
SIC: 3841 Surgical & Medical Instruments & Apparatus